These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 17602078

  • 1. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
    Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E.
    J Clin Oncol; 2007 Jul 01; 25(19):2735-40. PubMed ID: 17602078
    [Abstract] [Full Text] [Related]

  • 2. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer.
    Früh M, Rolland E, Pignon JP, Seymour L, Ding K, Tribodet H, Winton T, Le Chevalier T, Scagliotti GV, Douillard JY, Spiro S, Shepherd FA.
    J Clin Oncol; 2008 Jul 20; 26(21):3573-81. PubMed ID: 18640938
    [Abstract] [Full Text] [Related]

  • 3. Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer.
    Arriagada R, Dunant A, Pignon JP, Bergman B, Chabowski M, Grunenwald D, Kozlowski M, Le Péchoux C, Pirker R, Pinel MI, Tarayre M, Le Chevalier T.
    J Clin Oncol; 2010 Jan 01; 28(1):35-42. PubMed ID: 19933916
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
    Dunant A, Pignon JP, Le Chevalier T.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10.
    Pepe C, Hasan B, Winton TL, Seymour L, Graham B, Livingston RB, Johnson DH, Rigas JR, Ding K, Shepherd FA, National Cancer Institute of Canada and Intergroup Study JBR.10.
    J Clin Oncol; 2007 Apr 20; 25(12):1553-61. PubMed ID: 17442999
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG.
    Eur J Cardiothorac Surg; 2004 Jul 20; 26(1):173-82. PubMed ID: 15200998
    [Abstract] [Full Text] [Related]

  • 7. ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.
    Olaussen KA, Mountzios G, Soria JC.
    Curr Opin Pulm Med; 2007 Jul 20; 13(4):284-9. PubMed ID: 17534174
    [Abstract] [Full Text] [Related]

  • 8. Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
    Gauthier I, Ding K, Winton T, Shepherd FA, Livingston R, Johnson DH, Rigas JR, Whitehead M, Graham B, Seymour L.
    Lung Cancer; 2007 Mar 20; 55(3):357-63. PubMed ID: 17141357
    [Abstract] [Full Text] [Related]

  • 9. [Adjuvant chemotherapy in non-small cell lung cancer].
    Taillade L, Soria JC, André F, Grunenwald D, Dunant A, Pignon JP, Le Chevalier T.
    Bull Cancer; 2004 Jan 20; 91(1):63-7. PubMed ID: 14975806
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R.
    Rays; 2004 Jan 20; 29(4):435-7. PubMed ID: 15852732
    [Abstract] [Full Text] [Related]

  • 11. Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.
    Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Aviel-Ronen S, Seymour L, Whitehead M, Tsao MS, Shepherd FA, Reiman T.
    Clin Cancer Res; 2007 Feb 01; 13(3):994-9. PubMed ID: 17289895
    [Abstract] [Full Text] [Related]

  • 12. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
    Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy for non-small cell lung cancer.
    Solomon B, Bunn PA.
    Cancer Invest; 2007 Jun 01; 25(4):217-25. PubMed ID: 17612931
    [Abstract] [Full Text] [Related]

  • 14. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H, Dubey S, Gandara D.
    Oncologist; 2007 Mar 01; 12(3):331-7. PubMed ID: 17405898
    [Abstract] [Full Text] [Related]

  • 15. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology.
    J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710
    [Abstract] [Full Text] [Related]

  • 16. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul 01; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
    Dediu M, Horvat T, Tarlea A, Anghel R, Cordos I, Miron G, Iorga P, Alexandru A, Nistor C, Grozavu C, Savu C.
    Lung Cancer; 2005 Jan 01; 47(1):93-101. PubMed ID: 15603859
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
    Chen P, Li J, Ge LP, Dai CH, Li XQ.
    Respirology; 2010 Apr 01; 15(3):501-9. PubMed ID: 20210890
    [Abstract] [Full Text] [Related]

  • 19. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE, Rabin MS.
    Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [Abstract] [Full Text] [Related]

  • 20. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM.
    Eur J Cardiothorac Surg; 2005 Jun 01; 27(6):1086-91. PubMed ID: 15896623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.